Injecting Insulin Through Clothing?
There has been much discussion about the safety of injecting insulin through clothing. Some feel it is not very safe, while others do not want to be embarrassed publicly and show skin.
Glu.org conducted a survey to see how many people have actually injected insulin through clothing and 54% respondents or 198 people have admitted they have. What do you think, have you tried it?
There was only one scientific study “The Safety of Injecting Insulin Through Clothing” published in 1997 that considered this practice by researchers from Wayne State University in Detroit, published in the American Diabetes Association’s journal Diabetes Care. The results were that this practice was safe and convenient, but not recommended. There is some concern that the study was conducted 15 years ago. If it is safe and convenient why is it not recommended?
Read article from Diabetes Mine
Photo activated depot (PAD): Insulin through light
Photo activated depot (PAD) is a new method to administer insulin that is much easier and effective. It was developed by the researcher from University of Missouri – Kansas City, School of Pharmacy.
In this new technology, “insulin is linked to an insoluble polymer by a connection that can be broken with light.” This way, scientists are describing that insulin intake can be accomplished through light.
The PAD can be injected under the skin and this way absorbed by the body. The researchers are excited that this new technology may reduce the amount of injections, because the PADs may contain large quantities of the insulin. What do you think? Are you willing to try it?
Here is the academic article in the Angewandte Chemie
Three variants are genetic clues to insulin production
There are three genetic variants (TBC1D30, KANK1 and PAM) that have been identified by scientists, which influence the production of insulin. Scientists think that there are a series of genes that are interacting with each other and the person’s lifestyle (health, nutrition and exercise).
A new tool was used in the study called the exome array genotyping, less costly than genetic sequencing. This tool allows to test many people in an efficient manner and with this study more than 8,000 people were considered.
Learn more about the pharmaceutical company focused on the development, manufacture and commercialization of novel compounds: http://www.bostonti.com/